DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis
暂无分享,去创建一个
Jean-Louis Herrmann | Brigitte Gicquel | O. Schwartz | L. Tailleux | B. Gicquel | O. Neyrolles | J. Herrmann | P. Lagrange | P. Charles | Olivier Neyrolles | Olivier Schwartz | Ludovic Tailleux | J. de Blic | Jacques de Blic | P. Scheinmann | Nhan Pham-Thi | Anne Bergeron-Lafaurie | Patricia Charles | Pierre Scheinmann | Philippe H Lagrange | Abdellatif Tazi | A. Tazi | N. Pham‐Thi | A. Bergeron-Lafaurie | Anne Bergeron-Lafaurie
[1] G. Hunninghake,et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. , 1999, The European respiratory journal.
[2] T. Geijtenbeek,et al. Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.
[3] C. Figdor,et al. How C‐type lectins detect pathogens , 2005, Cellular microbiology.
[4] H. Klech. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. , 1989, The European respiratory journal.
[5] G. Hunninghake,et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. , 1999, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[6] O. Schwartz,et al. DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells , 2003, The Journal of experimental medicine.
[7] D. Voelker,et al. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. , 1995, Journal of immunology.
[8] David G. Russell,et al. Mycobacterium tuberculosis: here today, and here tomorrow , 2001, Nature Reviews Molecular Cell Biology.
[9] D. Weissman,et al. Constitutive and induced expression of DC‐SIGN on dendritic cell and macrophage subpopulations in situ and in vitro , 2002, Journal of leukocyte biology.
[10] R. Stokes,et al. Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient. , 1998, Journal of immunology.
[11] M. Morosini,et al. The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[12] O. Schwartz,et al. Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity. , 2005, The Biochemical journal.
[13] S. Kaufmann,et al. How can immunology contribute to the control of tuberculosis? , 2001, Nature Reviews Immunology.
[14] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[15] J. Abastado,et al. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. , 2004, Blood.
[16] H. Klech,et al. Clinical guidelines and indications for bronchoalveolar lavage (BAL): Report of the European Society of Pneumology Task Group on BAL. , 1990, The European respiratory journal.
[17] M. Daffé,et al. Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent , 1997, Infection and immunity.
[18] T. Geijtenbeek,et al. Pathogens target DC‐SIGN to influence their fate DC‐SIGN functions as a pathogen receptor with broad specificity , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[19] J. Ernst,et al. Macrophage Receptors for Mycobacterium tuberculosis , 1998, Infection and Immunity.
[20] J. Rodríguez-Fernández,et al. DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-β, and Anti-Inflammatory Agents1 , 2002, The Journal of Immunology.
[21] T. Graeber,et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells , 2005, Nature Medicine.
[22] B M Curtis,et al. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[23] L. Tailleux,et al. How is the phagocyte lectin keyboard played? Master class lesson by Mycobacterium tuberculosis. , 2003, Trends in microbiology.
[24] H. Yeager,et al. Nonopsonic uptake of Mycobacterium avium complex by human monocytes and alveolar macrophages. , 1992, The Journal of laboratory and clinical medicine.
[25] V. Boussiotis,et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. , 2000, The Journal of clinical investigation.
[26] J. Heuser,et al. Trafficking and Release of Mycobacterial Lipids from Infected Macrophages , 2000, Traffic.
[27] B. Gicquel,et al. The Cell Surface Receptor DC-SIGN Discriminates betweenMycobacterium Species through Selective Recognition of the Mannose Caps on Lipoarabinomannan* , 2003, The Journal of Biological Chemistry.
[28] J. Abastado,et al. Constrained Intracellular Survival of Mycobacterium tuberculosis in Human Dendritic Cells 1 , 2003, The Journal of Immunology.
[29] M. Horwitz,et al. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.
[30] J. Ficker,et al. Inverse Correlation of Maturity and Antibacterial Activity in Human Dendritic Cells1 , 2005, The Journal of Immunology.
[31] M. Schlaak,et al. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases. , 2000, European cytokine network.
[32] R. Pauwels,et al. Identification and characterization of human pulmonary dendritic cells. , 2005, American journal of respiratory cell and molecular biology.
[33] B. Spellberg,et al. Type 1/Type 2 immunity in infectious diseases. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] J. Ellner,et al. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. , 1994, Journal of immunology.
[35] G. Hunninghake,et al. ATS/ERS/WASOG statement on sarcoidosis , 1999 .
[36] D. Russell,et al. Mycobacterial surface moieties are released from infected macrophages by a constitutive exocytic event. , 2001, European journal of cell biology.
[37] R. Kirsch,et al. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells , 1996, Infection and immunity.